The sirens' songs of confirmatory sepsis trials
- 1 December 1998
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 26 (12), 1927-1931
- https://doi.org/10.1097/00003246-199812000-00001
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsisCritical Care Medicine, 1998
- Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shockThe Lancet, 1998
- Confirmatory interleukin-1 receptor antagonist trial in severe sepsisCritical Care Medicine, 1997
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- The Effects of Ibuprofen on the Physiology and Survival of Patients with SepsisNew England Journal of Medicine, 1997
- Treatment of Severe Systemic Inflammatory Response Syndrome and Sepsis With a Novel Bradykinin Antagonist, Deltibant (CP-0127)Results of a Randomized, Double-blind, Placebo-Controlled TrialPublished by American Medical Association (AMA) ,1997
- INTERSEPTCritical Care Medicine, 1996
- Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis SyndromeJAMA, 1995
- Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trialCritical Care Medicine, 1994
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis SyndromeJAMA, 1994